Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial

Lancet Gastroenterol Hepatol. 2024 Aug;9(8):687. doi: 10.1016/S2468-1253(24)00130-4.

Authors

Jasmijn Maria Westerhoff¹, Nina Niu Sanford², William Adrian Hall³

Affiliations

¹ Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht 3508 GA, Netherlands. Electronic address: [email protected].
² Department of Radiation Oncology, Southwestern Medical Center, University of Texas, Dallas, TX, USA.
³ Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.

PMID: 38971163
DOI: 10.1016/S2468-1253(24)00130-4

No abstract available

Publication types

Letter

MeSH terms

Ablation Techniques / methods
Fluorouracil / administration & dosage
Fluorouracil / therapeutic use
Humans
Pancreatic Neoplasms* / pathology
Pancreatic Neoplasms* / surgery
Pancreatic Neoplasms* / therapy
Randomized Controlled Trials as Topic
Treatment Outcome

Substances

Fluorouracil